+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Atrial Fibrillation Market Research Report by Product, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4858006
  • Report
  • July 2021
  • Region: Global
  • 197 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Atrial Fibrillation Market will Grow to USD 13,899.16 Million by 2026, at a CAGR of 13.52%

FEATURED COMPANIES

  • Abbott Laboratories
  • AtriCure, Inc.
  • CardioFocus, Inc.
  • CathRx Ltd
  • Japan Lifeline Co
  • MicroPort Scientific Corp
The Global Atrial Fibrillation Market size was estimated at USD 6,492.50 Million in 2020 and expected to reach USD 7,348.71 Million in 2021, at a Compound Annual Growth Rate (CAGR) 13.52% to reach USD 13,899.16 Million by 2026.



Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Atrial Fibrillation to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the Atrial Fibrillation Market was examined across Access Devices, Cardiac Monitors or Implantable Loop Recorder, EP Ablation Catheters, EP Diagnostic Catheter, Intracardiac Echocardiography, Left Atrial Appendage Closure Devices, and Mapping and Recording Systems.
  • Based on Device, the Atrial Fibrillation Market was examined across Non-Surgical Devices and Surgical Devices. The Non-Surgical Devices was further studied across Access Devices, Advanced Diagnostic Catheters, Cardiac Monitors, Conventional Diagnostic Catheters, Diagnostic Catheters, Electric Cardioversion, Intracardiac Echocardiography (ICE) Systems, Left Atrial Appendage and Closure Devices, and Mapping and Recording Systems. The Surgical Devices was further studied across Catheter Ablation, Cryoablation, Laser Based Catheter Ablation, Maze Surgery, Microwave Based Catheter Ablation, Navigational Advanced Mapping Accessories, and Radiofrequency Catheter Ablation.
  • Based on Geography, the Atrial Fibrillation Market was examined across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas was further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific was further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa was further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. This ongoing research amplifies this research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Atrial Fibrillation Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Atrial Fibrillation Market, including Abbott Laboratories, Acesion Pharma ApS, AFreeze GmbH, AtriCure, Inc., AuriGen Medical, BIOTRONIK SE & CO. KG, Boston Scientific Corporation, CardioFocus, Inc., Carima, Inc., CathEffects Inc., CathRx Ltd, Endo Photonix, Inc, GE Healthcare, Japan Lifeline Co, Johnson & Johnson Services, Inc., Koninklijke Philips N.V, Medtronic PLC, MicroPort Scientific Corp, Osypka AG, Siemens Healthineers AG, St. Jude Medical, Inc., Stroke Foundation, TZ Medical, Inc., and Vanguard AG.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Atrial Fibrillation Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Atrial Fibrillation Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Atrial Fibrillation Market?
4. What is the competitive strategic window for opportunities in the Global Atrial Fibrillation Market?
5. What are the technology trends and regulatory frameworks in the Global Atrial Fibrillation Market?
6. What is the market share of the leading vendors in the Global Atrial Fibrillation Market?
7. What modes and strategic moves are considered suitable for entering the Global Atrial Fibrillation Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • AtriCure, Inc.
  • CardioFocus, Inc.
  • CathRx Ltd
  • Japan Lifeline Co
  • MicroPort Scientific Corp
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Product Outlook
3.4. Device Outlook
3.5. Geography Outlook
3.6. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of atrial fibrillation in geriatric population
5.1.1.2. Technology advancements in treatment and diagnostic methods to atrial fibrillation
5.1.2. Restraints
5.1.2.1. Dearth of skilled professionals
5.1.2.2. Elevated price of treatment
5.1.3. Opportunities
5.1.3.1. Increasing preference of catheter ablation for cardiac arrhythmia treatment
5.1.3.2. R&D activities to innovate new technologies for early detection and effective treatment methods.
5.1.4. Challenges
5.1.4.1. Unfavorable preference of pharmaceutical interventions (drugs) over AF treatment devices
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Atrial Fibrillation Market, by Product
6.1. Introduction
6.2. Access Devices
6.3. Cardiac Monitors or Implantable Loop Recorder
6.4. EP Ablation Catheters
6.5. EP Diagnostic Catheter
6.6. Intracardiac Echocardiography
6.7. Left Atrial Appendage Closure Devices
6.8. Mapping and Recording Systems

7. Atrial Fibrillation Market, by Device
7.1. Introduction
7.2. Non-Surgical Devices
7.2.1. Access Devices
7.2.2. Advanced Diagnostic Catheters
7.2.3. Cardiac Monitors
7.2.4. Conventional Diagnostic Catheters
7.2.4.1. Fixed Diagnostic Catheters
7.2.4.2. Steerable Diagnostic Catheters
7.2.5. Diagnostic Catheters
7.2.6. Electric Cardioversion
7.2.7. Intracardiac Echocardiography (ICE) Systems
7.2.8. Left Atrial Appendage and Closure Devices
7.2.9. Mapping and Recording Systems
7.3. Surgical Devices
7.3.1. Catheter Ablation
7.3.2. Cryoablation
7.3.3. Laser Based Catheter Ablation
7.3.4. Maze Surgery
7.3.5. Microwave Based Catheter Ablation
7.3.6. Navigational Advanced Mapping Accessories
7.3.7. Radiofrequency Catheter Ablation
7.3.7.1. Conventional RF Ablation Catheters
7.3.7.2. Irrigated-tip RF Ablation Catheters

8. Americas Atrial Fibrillation Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Atrial Fibrillation Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Thailand

10. Europe, Middle East & Africa Atrial Fibrillation Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. Abbott Laboratories
12.2. Acesion Pharma ApS
12.3. AFreeze GmbH
12.4. AtriCure, Inc.
12.5. AuriGen Medical
12.6. BIOTRONIK SE & CO. KG
12.7. Boston Scientific Corporation
12.8. CardioFocus, Inc.
12.9. Carima, Inc.
12.10. CathEffects Inc.
12.11. CathRx Ltd
12.12. Endo Photonix, Inc
12.13. GE Healthcare
12.14. Japan Lifeline Co
12.15. Johnson & Johnson Services, Inc.
12.16. Koninklijke Philips N.V
12.17. Medtronic PLC
12.18. MicroPort Scientific Corp
12.19. Osypka AG
12.20. Siemens Healthineers AG
12.21. St. Jude Medical, Inc.
12.22. Stroke Foundation
12.23. TZ Medical, Inc.
12.24. Vanguard AG

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
FIGURE 3. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2020 (USD MILLION)
FIGURE 4. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 5. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 6. GLOBAL ATRIAL FIBRILLATION MARKET: MARKET DYNAMICS
FIGURE 7. GLOBAL ATRIAL FIBRILLATION MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 8. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
FIGURE 9. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2026
FIGURE 11. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY ACCESS DEVICES, 2018-2026 (USD MILLION)
FIGURE 12. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY ACCESS DEVICES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 13. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY CARDIAC MONITORS OR IMPLANTABLE LOOP RECORDER, 2018-2026 (USD MILLION)
FIGURE 14. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY CARDIAC MONITORS OR IMPLANTABLE LOOP RECORDER, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 15. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY EP ABLATION CATHETERS, 2018-2026 (USD MILLION)
FIGURE 16. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY EP ABLATION CATHETERS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 17. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY EP DIAGNOSTIC CATHETER, 2018-2026 (USD MILLION)
FIGURE 18. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY EP DIAGNOSTIC CATHETER, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 19. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY INTRACARDIAC ECHOCARDIOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 20. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY INTRACARDIAC ECHOCARDIOGRAPHY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 21. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY LEFT ATRIAL APPENDAGE CLOSURE DEVICES, 2018-2026 (USD MILLION)
FIGURE 22. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY LEFT ATRIAL APPENDAGE CLOSURE DEVICES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 23. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY MAPPING AND RECORDING SYSTEMS, 2018-2026 (USD MILLION)
FIGURE 24. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY MAPPING AND RECORDING SYSTEMS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 25. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2020 VS 2026 (%)
FIGURE 26. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2020 VS 2026 (USD MILLION)
FIGURE 27. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2026
FIGURE 28. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, 2018-2026 (USD MILLION)
FIGURE 29. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 30. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY ACCESS DEVICES, 2018-2026 (USD MILLION)
FIGURE 31. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY ACCESS DEVICES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 32. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY ADVANCED DIAGNOSTIC CATHETERS, 2018-2026 (USD MILLION)
FIGURE 33. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY ADVANCED DIAGNOSTIC CATHETERS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 34. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY CARDIAC MONITORS, 2018-2026 (USD MILLION)
FIGURE 35. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY CARDIAC MONITORS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 36. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, 2018-2026 (USD MILLION)
FIGURE 37. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 38. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY FIXED DIAGNOSTIC CATHETERS, 2018-2026 (USD MILLION)
FIGURE 39. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY FIXED DIAGNOSTIC CATHETERS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 40. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY STEERABLE DIAGNOSTIC CATHETERS, 2018-2026 (USD MILLION)
FIGURE 41. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY STEERABLE DIAGNOSTIC CATHETERS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 42. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY DIAGNOSTIC CATHETERS, 2018-2026 (USD MILLION)
FIGURE 43. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY DIAGNOSTIC CATHETERS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 44. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY ELECTRIC CARDIOVERSION, 2018-2026 (USD MILLION)
FIGURE 45. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY ELECTRIC CARDIOVERSION, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 46. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY INTRACARDIAC ECHOCARDIOGRAPHY (ICE) SYSTEMS, 2018-2026 (USD MILLION)
FIGURE 47. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY INTRACARDIAC ECHOCARDIOGRAPHY (ICE) SYSTEMS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 48. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY LEFT ATRIAL APPENDAGE AND CLOSURE DEVICES, 2018-2026 (USD MILLION)
FIGURE 49. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY LEFT ATRIAL APPENDAGE AND CLOSURE DEVICES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 50. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY MAPPING AND RECORDING SYSTEMS, 2018-2026 (USD MILLION)
FIGURE 51. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY MAPPING AND RECORDING SYSTEMS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 52. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, 2018-2026 (USD MILLION)
FIGURE 53. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 54. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY CATHETER ABLATION, 2018-2026 (USD MILLION)
FIGURE 55. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY CATHETER ABLATION, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 56. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY CRYOABLATION, 2018-2026 (USD MILLION)
FIGURE 57. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY CRYOABLATION, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 58. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY LASER BASED CATHETER ABLATION, 2018-2026 (USD MILLION)
FIGURE 59. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY LASER BASED CATHETER ABLATION, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 60. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY MAZE SURGERY, 2018-2026 (USD MILLION)
FIGURE 61. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY MAZE SURGERY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 62. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY MICROWAVE BASED CATHETER ABLATION, 2018-2026 (USD MILLION)
FIGURE 63. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY MICROWAVE BASED CATHETER ABLATION, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 64. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY NAVIGATIONAL ADVANCED MAPPING ACCESSORIES, 2018-2026 (USD MILLION)
FIGURE 65. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY NAVIGATIONAL ADVANCED MAPPING ACCESSORIES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 66. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, 2018-2026 (USD MILLION)
FIGURE 67. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 68. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL RF ABLATION CATHETERS, 2018-2026 (USD MILLION)
FIGURE 69. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL RF ABLATION CATHETERS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 70. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY IRRIGATED-TIP RF ABLATION CATHETERS, 2018-2026 (USD MILLION)
FIGURE 71. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY IRRIGATED-TIP RF ABLATION CATHETERS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 72. AMERICAS ATRIAL FIBRILLATION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 73. AMERICAS ATRIAL FIBRILLATION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 74. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ATRIAL FIBRILLATION MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 75. ARGENTINA ATRIAL FIBRILLATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 76. BRAZIL ATRIAL FIBRILLATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 77. CANADA ATRIAL FIBRILLATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 78. MEXICO ATRIAL FIBRILLATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 79. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 80. ASIA-PACIFIC ATRIAL FIBRILLATION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 81. ASIA-PACIFIC ATRIAL FIBRILLATION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 82. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ATRIAL FIBRILLATION MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 83. AUSTRALIA ATRIAL FIBRILLATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 84. CHINA ATRIAL FIBRILLATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 85. INDIA ATRIAL FIBRILLATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 86. INDONESIA ATRIAL FIBRILLATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 87. JAPAN ATRIAL FIBRILLATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 88. MALAYSIA ATRIAL FIBRILLATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 89. PHILIPPINES ATRIAL FIBRILLATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 90. SINGAPORE ATRIAL FIBRILLATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 91. SOUTH KOREA ATRIAL FIBRILLATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 92. THAILAND ATRIAL FIBRILLATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 93. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 94. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 95. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 96. FRANCE ATRIAL FIBRILLATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 97. GERMANY ATRIAL FIBRILLATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 98. ITALY ATRIAL FIBRILLATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 99. NETHERLANDS ATRIAL FIBRILLATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 100. QATAR ATRIAL FIBRILLATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 101. RUSSIA ATRIAL FIBRILLATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 102. SAUDI ARABIA ATRIAL FIBRILLATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 103. SOUTH AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 104. SPAIN ATRIAL FIBRILLATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 105. UNITED ARAB EMIRATES ATRIAL FIBRILLATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 106. UNITED KINGDOM ATRIAL FIBRILLATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 107. GLOBAL ATRIAL FIBRILLATION MARKET: FPNV POSITIONING MATRIX
FIGURE 108. GLOBAL ATRIAL FIBRILLATION MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 109. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ATRIAL FIBRILLATION MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL ATRIAL FIBRILLATION MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY ACCESS DEVICES, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY CARDIAC MONITORS OR IMPLANTABLE LOOP RECORDER, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY EP ABLATION CATHETERS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 8. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY EP DIAGNOSTIC CATHETER, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY INTRACARDIAC ECHOCARDIOGRAPHY, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 10. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY LEFT ATRIAL APPENDAGE CLOSURE DEVICES, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 11. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY MAPPING AND RECORDING SYSTEMS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 12. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2026 (USD MILLION)
TABLE 13. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY NON-SURGICAL DEVICES, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 14. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY ACCESS DEVICES, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 15. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY ADVANCED DIAGNOSTIC CATHETERS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 16. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY CARDIAC MONITORS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 17. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL DIAGNOSTIC CATHETERS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 18. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY FIXED DIAGNOSTIC CATHETERS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 19. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY STEERABLE DIAGNOSTIC CATHETERS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 20. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY DIAGNOSTIC CATHETERS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 21. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY ELECTRIC CARDIOVERSION, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 22. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY INTRACARDIAC ECHOCARDIOGRAPHY (ICE) SYSTEMS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 23. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY LEFT ATRIAL APPENDAGE AND CLOSURE DEVICES, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 24. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY MAPPING AND RECORDING SYSTEMS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 25. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY SURGICAL DEVICES, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 26. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY CATHETER ABLATION, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 27. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY CRYOABLATION, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 28. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY LASER BASED CATHETER ABLATION, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 29. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY MAZE SURGERY, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 30. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY MICROWAVE BASED CATHETER ABLATION, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 31. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY NAVIGATIONAL ADVANCED MAPPING ACCESSORIES, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 32. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY RADIOFREQUENCY CATHETER ABLATION, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 33. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY CONVENTIONAL RF ABLATION CATHETERS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 34. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY IRRIGATED-TIP RF ABLATION CATHETERS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 35. AMERICAS ATRIAL FIBRILLATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 36. AMERICAS ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 37. AMERICAS ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2026 (USD MILLION)
TABLE 38. ARGENTINA ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 39. ARGENTINA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2026 (USD MILLION)
TABLE 40. BRAZIL ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 41. BRAZIL ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2026 (USD MILLION)
TABLE 42. CANADA ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 43. CANADA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2026 (USD MILLION)
TABLE 44. MEXICO ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 45. MEXICO ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2026 (USD MILLION)
TABLE 46. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 47. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 48. UNITED STATES ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2026 (USD MILLION)
TABLE 49. ASIA-PACIFIC ATRIAL FIBRILLATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 50. ASIA-PACIFIC ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 51. ASIA-PACIFIC ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2026 (USD MILLION)
TABLE 52. AUSTRALIA ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 53. AUSTRALIA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2026 (USD MILLION)
TABLE 54. CHINA ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 55. CHINA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2026 (USD MILLION)
TABLE 56. INDIA ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 57. INDIA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2026 (USD MILLION)
TABLE 58. INDONESIA ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 59. INDONESIA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2026 (USD MILLION)
TABLE 60. JAPAN ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 61. JAPAN ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2026 (USD MILLION)
TABLE 62. MALAYSIA ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 63. MALAYSIA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2026 (USD MILLION)
TABLE 64. PHILIPPINES ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 65. PHILIPPINES ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2026 (USD MILLION)
TABLE 66. SINGAPORE ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 67. SINGAPORE ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2026 (USD MILLION)
TABLE 68. SOUTH KOREA ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 69. SOUTH KOREA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2026 (USD MILLION)
TABLE 70. THAILAND ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 71. THAILAND ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2026 (USD MILLION)
TABLE 72. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 73. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2026 (USD MILLION)
TABLE 75. FRANCE ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 76. FRANCE ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2026 (USD MILLION)
TABLE 77. GERMANY ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 78. GERMANY ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2026 (USD MILLION)
TABLE 79. ITALY ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 80. ITALY ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2026 (USD MILLION)
TABLE 81. NETHERLANDS ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 82. NETHERLANDS ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2026 (USD MILLION)
TABLE 83. QATAR ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 84. QATAR ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2026 (USD MILLION)
TABLE 85. RUSSIA ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 86. RUSSIA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2026 (USD MILLION)
TABLE 87. SAUDI ARABIA ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 88. SAUDI ARABIA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2026 (USD MILLION)
TABLE 89. SOUTH AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 90. SOUTH AFRICA ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2026 (USD MILLION)
TABLE 91. SPAIN ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 92. SPAIN ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2026 (USD MILLION)
TABLE 93. UNITED ARAB EMIRATES ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 94. UNITED ARAB EMIRATES ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2026 (USD MILLION)
TABLE 95. UNITED KINGDOM ATRIAL FIBRILLATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 96. UNITED KINGDOM ATRIAL FIBRILLATION MARKET SIZE, BY DEVICE, 2018-2026 (USD MILLION)
TABLE 97. GLOBAL ATRIAL FIBRILLATION MARKET: SCORES
TABLE 98. GLOBAL ATRIAL FIBRILLATION MARKET: BUSINESS STRATEGY
TABLE 99. GLOBAL ATRIAL FIBRILLATION MARKET: PRODUCT SATISFACTION
TABLE 100. GLOBAL ATRIAL FIBRILLATION MARKET: RANKING
TABLE 101. GLOBAL ATRIAL FIBRILLATION MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 102. GLOBAL ATRIAL FIBRILLATION MARKET: MERGER & ACQUISITION
TABLE 103. GLOBAL ATRIAL FIBRILLATION MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 104. GLOBAL ATRIAL FIBRILLATION MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 105. GLOBAL ATRIAL FIBRILLATION MARKET: INVESTMENT & FUNDING
TABLE 106. GLOBAL ATRIAL FIBRILLATION MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 107. GLOBAL ATRIAL FIBRILLATION MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • Acesion Pharma ApS
  • AFreeze GmbH
  • AtriCure, Inc.
  • AuriGen Medical
  • BIOTRONIK SE & CO. KG
  • Boston Scientific Corporation
  • CardioFocus, Inc.
  • Carima, Inc.
  • CathEffects Inc.
  • CathRx Ltd
  • Endo Photonix, Inc
  • GE Healthcare
  • Japan Lifeline Co
  • Johnson & Johnson Services, Inc.
  • Koninklijke Philips N.V
  • Medtronic PLC
  • MicroPort Scientific Corp
  • Osypka AG
  • Siemens Healthineers AG
  • St. Jude Medical, Inc.
  • Stroke Foundation
  • TZ Medical, Inc.
  • Vanguard AG
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll